Selection of Highly Metastatic Variants of Different Human Prostatic Carcinomas Using Orthotopic Implantation in Nude Mice

Clinical Cancer Research

Volumn 2, Issue 9, 1996, Pages 1627-1636

  Pettaway, Curtis A ^a,b   Pathak, Sen ^a   Greene, Graham ^a   Ramirez, Edilberto ^a   Wilson, Michael R ^a   Killion, Jerald J ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; PROSTATE SPECIFIC ANTIGEN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; BONE TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; GENETIC VARIABILITY; GENETICS; HUMAN; KARYOTYPING; LIVER TUMOR; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MOUSE; NUDE MOUSE; ORCHIECTOMY; PATHOLOGY; PROSTATE TUMOR;

ANIMALS; BONE NEOPLASMS; CELL DIVISION; CULTURE MEDIA; DIHYDROTESTOSTERONE; HUMANS; KARYOTYPING; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; ORCHIECTOMY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

EID: 0030223057     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics. Cancer (Phila ), 45: 8-30, 1995.
2. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C , de Kernion, J. B., Ratliff, T. L., Kavoussi, L., Dalkin, B. L., Waters, W B., MacFarlane, M. T., and Southwick, P. C. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283-1290, 1995.
3. Catalona, W. J., Smith, D. S., Ratliff, T. L , and Basler, J. W. Detection of organ confined prostate cancer is increased through prostate-specific antigen based screening. J. Am. Med. Assoc., 270: 948-954, 1993.
4. Eisenberger, M. A. Chemotherapy and palliation in prostate cancer. In: D. A. S. Crawford (ed.), Cancer of the Prostate, pp , 369-396. New York: Marcel Dekker, 1993.
5. Fidler, I. J. Critical factors in the biology of human cancer metastasis. Cancer Res., 50. 6130-6138, 1990.
6. Ware, J. L. Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev., 12: 287-301, 1993.
7. Fidler, I. J. The nude mouse model for studies of human cancer metastasis In: V Schirrmacher and R. Schwartz-Abliez (eds.), pp. 11-17. Berlin: Springer-Verlag, 1989.
8. Giavazzi, R., Campbell, D. E., Jessup, J. M., Cleary, K., and Fidler, I. J. Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res., 46: 1928-1933, 1986.
9. Morikawa, K., Walker, S. M., Jessup, J. M., and Fidler, I. J In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res., 48: 1943-1948, 1988.
10. Naito, S., von Eschenbach, A. C., Giavazzi, R., and Fidler, I. J. Growth and metastasis of tumor cells isolated from a renal cell carcinoma implanted into different organs of nude mice. Cancer Res., 46: 4109-4115, 1986.
11. Price, J. E., Polyzos, A., Zhang, R. D., and Daniels, L. M. Tumorigenicity and metastasis of human breast carcinoma lines in nude mice. Cancer Res., 50: 717-721, 1990.
12. Ahlering, T. E., Dubeau, L., and lones, P. A A new in vivo model to study invasion and metastasis of human bladder carcinoma. Cancer Res., 47: 6660-6665, 1985.
13. Dinney, C. P. N., Fishbeck, R., Singh, R. K., Eve, B., Pathak, S., Brown, N., Xie, B., Fan, D., Bucana, C. D., Fidler, I. J., and Killion, J. J. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J. Urol., 154: 1532-1538, 1995.
14. McLemore, T. L., Liu, M. C., Blacker, P. C., Gregg, M., Alley, M. C., Abbott, B. J., Shoemaker, R. H., Bohlman, M. E., Litterst, C. C., Hubbard, W. C., Brennan, R. H., McMahon, J. B., Fine, D. L., Eggleston, J. C., Mayo, J. G., and Boyd, M. R. Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice. Cancer Res., 47: 5132-5140, 1987.
15. Stephenson, R. A., Dinney, C. P. N., Gohji, K., Ordonez, N. G., Killion, J. J., and Fidler, I. J. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl. Cancer Inst., 84: 951-957, 1992
16. Pettaway, C. A., Stephenson, R. A., and Fidler, I. J. Development of orthotopic models of metastatic human prostate cancer. Cancer Bull. (Houst.), 45: 424-429, 1993.
17. Fu, X., Herrera, H., and Hoffman, R. M. Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue. Int. J. Cancer, 52: 987-990, 1992.
18. Gleave, M., Hsieh, J. T., Gao, C., von Eschenbach, A. C., and Chung, L. W. K. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res., 51: 3753-3761, 1991.
19. Pretlow, T. G., Delmoro, C. M., Dilley, G. G., Spadafora, C. G., and Pretlow, T. P. Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res., 51: 3814-3817, 1991.
20. Koslowski, J. M., Fidler, I. J., Campbell, D., Xu, Z., Kaighn, M. E., and Hart, I. R. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res., 44: 3522-3529, 1984.
21. Horoszewicz, J. S., Leong, S. S., Chu, T. M., Wajsman, Z. L., Friedman, M., Papsidero, L., Kim, U., Chai, L. S., Kakati, S., Arya, S. K., and Sandberg, A. A. The LNCaP cell line: a new model for studies on human prostatic carcinoma. In: D. S. Coffey (ed.), Models for Prostate Cancer, pp., 115-132. New York: Alan Liss, 1980.
22. Van Steenbrugge, G. J., Groen, M., Vandongen, J. W., Bolt, J., van der Korput, H., Trapman, J., Hasenson, M., and Horoszewicz, J. The human prostatic carcinoma cell line LNCaP and its derivatives. Urol. Res., 17: 71-77, 1989.
23. Kaighn, M. E., Narayan, K. S., Ohnuki, Y., Lechner, J. F., and Jones, L. W. Establishment and characterization of a human prostate carcinoma cell line (PC-3). Invest. Urol., 17: 16-23, 1979.
24. Giavazzi, R., Jessup, J. M., Campbell, D. E., Walker, S. M., and Fidler, I. J. Experimental nude mouse model of colorectal cancer liver metastases. J. Natl. Cancer Inst., 77: 1303-1307, 1986.
25. Peehl, D. M., and Stamey, T. A. Serial propagation of adult human prostatic epithelial cells with cholera toxin. In Vitro, 20: 981-986, 1984.
26. Pathak, S. Chromosome banding techniques. J. Reprod. Med., 17: 25-28, 1976.
27. Zar, J. M. Biostatistical analysis, Ed. 2, pp. 162-186. Englewood Cliffs: Prentice Hall, 1984.
28. Fidler, I. J. Selection of successive tumor lines for metastasis. New Biol., 242: 148-149, 1973.
29. Paget, S. The distribution of secondary growths in cancer of the breast. Lancet, 1: 571-573, 1889.
30. Arguello, F., Baggs, R. B., and Frantz, C. N. A murine model of experimental metastasis to bone and bone marrow. Cancer Res., 48: 6876-6881, 1988.
31. Shevrin, D. H., Kukreja, S. C., Ghosh, L., and Lad, T. E. Development of skeletal metastasis by human prostate cancer in athymic nude mice Clin. Exp. Metastasis, 6. 401-409, 1988.
32. Thalman, G. N., Anezinis, P. E., Chang, S. M., Zhau, H. E., Kim, E. E., Hopwood, V. L., Pathak, S., von Eschenbach, A. C., and Chung, L. W. K. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res., 54: 2577-2581, 1994.
33. Wang, M., and Sterns, M. E. Isolation and characterization OFPC-3 human prostatic sublines which preferentially metastasize to select organs in SCID mice. Differentiation, 48: 115-125, 1991.
34. Haq, M., Goltzman, D., Tremblay, G., and Brodt, P. Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Cancer Res., 52: 4613-4619, 1992.
35. Stearns, M. E., and Wang, M. Regulation of kinesin expression and type IV collagenase secretion in invasive human prostate PC-3 tumor sublines. Cancer Res., 51: 5866-5875, 1991.
36. Chackal-Roy, M., Niemeyer, C., Moore, M., and Zetter, B. R. Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. J. Clin. Invest., 84: 43-50, 1989.
37. Isaacs, J. T., Wake, N., Coffey, D. S., and Sandberg, A. A. Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system. Cancer Res., 42: 2353-2361, 1982.
38. Talmadge, J. E., Wolman, S. R., and Fidler, I. J. Evidence for the clonal origin of spontaneous metastases. Science (Washington DC), 217: 361-363, 1982.
39. Newmark, J. R., Hardy, D. O., Tonb, D. C., Carter, B. S., Epstein, J. I., Isaacs, W. B., Brown, T. R., and Barrack, E. R. Androgen receptor gene mutations in human prostate cancer. Proc. Natl. Acad. Sci. USA, 89: 6319-6323, 1992.
40. Wu, H. C., Hsieh, J. T., Gleave, M. E., Brown, N. M., Pathak, S., and Chung, L. W. K. Derivation of androgen-independent human LN-CaP prostatic cancer cell sublines: role of bone stromal cells. Int. J. Cancer, 57: 406-412, 1994.
41. Culig, Z., Hobisch, A., Cronaver, M. V., Cato, A. C. B., Hittmar, A., Radmayr, C., Eberle, J., Bartsch, G., and Klocker, H. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol. Endocrinol., 7: 1541-1550, 1993.
42. Isaacs, J. T., and Kyprianou, N. Development of androgen-independent tumor cells and their implication for the treatment of prostatic cancer. Urol. Res., 15: 133-138, 1987.
43. Oesterling, J. E. Prostate-specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145: 907-923, 1991.
44. Babaian, R. J., Troncoso, P., Steelhammer, L. C., Loreta-Trull, L. J., and Ramirez, E. I. Tumor volume and prostate-specific antigen: implications for early detection and defining a window of curability. J. Urol., 154: 1808-1812, 1995.
45. Gleave, M. E., Hsieh, J. T., Wu, H. C., von Eschenbach, A. C., and Chung, L. W. K. Serum prostate-specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res., 52: 1598-1605, 1992.
46. Young, C. Y. F., Montgomery, B. T., Andrews, P. E., Qiu, S., Bilhartz. D. L., and Tindall, D. J. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res., 51: 3748-3752, 1991.
47. Hsieh, J. T., Wu, H. C., Gleave, M. E., von Eschenbach, A. C., and Chung, L. W. K. Autocrine regulation of prostate-specific antigen gene expression in a human prostate cancer (LNCaP) cell line. Cancer Res., 53: 2852-2857, 1993.
48. Cohen, P., Graves, H. C. B., Peehl, D. M., Kamarei, M., Giuice, L. C., and Rosenfeld, R. G. Prostate-specific antigen (PSA) is an insulin-like growth factor binding proteIN-3 protease found in seminal plasma. J. Clin Endocrinol. Metab., 75: 1046-1053, 1992.
49. Pietrzkowski, Z., Mulholland, G , Gomella, L., Jameson, B. A., Wernicke, D., and Baserga, R Inhibition of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res., 53: 1102-1106, 1993.
50. Delworth, M. G., Nishioka, K., Pettaway, C. A., Gutman, M., Killion, J. J., von Eschenbach, A. C., and Fidler, I. J. Systemic administration of 4-amidinoindanon-1-(2′-amidino)-hydrazone, a new inhibitor of S-adenosylmethionine decarboxylase, produces cytostasis of human prostate cancer in athymic nude mice. Int. J. Oncol., 6: 293-299, 1995.